SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-366344
Filing Date
2017-12-11
Accepted
2017-12-11 16:52:57
Documents
5
Period of Report
2017-12-11
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d508860d8k.htm 8-K 29891
2 EX-10.1 d508860dex101.htm EX-10.1 50546
3 EX-10.2 d508860dex102.htm EX-10.2 50311
4 EX-10.3 d508860dex103.htm EX-10.3 60498
5 EX-99.1 d508860dex991.htm EX-99.1 11980
  Complete submission text file 0001193125-17-366344.txt   204518
Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36517 | Film No.: 171250037
SIC: 2834 Pharmaceutical Preparations